Essential Partners’s Ingevity NGVT Stock Holding History

Essential Partners’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75	Hold	1	–	–	﹤0.01%	2772
2026 Q1	$71	Hold	1	–	–	﹤0.01%	2755
2025 Q4	$59	Buy	+1	New	+$54	﹤0.01%	2622

Other funds holding NGVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Essential Partners's NGVT Position: Q2 2026 in Review

Essential Partners held its Ingevity (NGVT) position steady in Q2 2026 at 1 share worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Essential Partners first reported a position in NGVT in Q4 2025 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

Essential Partners held 1 share of Ingevity worth $75 as of Q2 2026.
Essential Partners left its Ingevity share count unchanged in Q2 2026.
Ingevity made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2772 holding.
Essential Partners first reported a position in Ingevity in Q4 2025 and has held it in 3 quarters since.
315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.